CME-Directory

New medications in hepatology are constantly being tested in clinical trials and are now being rapidly approved by the FDA with entry into the American treatment market. At this conference we will be reviewing those new medications that are available, or will soon be available, and discussing their relative values. The results of trials using new drugs to treat chronic viral hepatitis B and C will be reviewed and the clinical use of these drugs will be explained in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

This course is designed to provide attendees with a high-yield and broad review of stroke and other cerebrovascular diseases, including cerebrovascular physiology and pathophysiology, primary and secondary stroke prevention, acute ischemic stroke and evaluation and management, neuro-critical care, brain aneurysms and vascular malformations, intracranial hemorrhage, and complications of stroke.

Live Online Q&A - Long-term effects of childbirth in MS

As 80% of young patients with recent-onset psychosis will experience a second episode, and adherence problems are frequent, these patients may benefit from treatment with long-acting atypical antipsychotic medication. The presentation is given by Prof Michael Davidson, Professor of Psychiatry at the Sackler School of Medicine and Director the Department of Psychiatry, Sheba Medical Centre, Tel-Aviv, Israel.

This two-day workshop will address the need to integrate quality improvement and safety into medical education. Designed for health profession educators, this workshop will disseminate the knowledge and tools necessary to successfully implement QI and safety education in undergraduate medical education (UME), graduate medical education (GME), continuing medical education (CME), and allied health schools.